Quality of Life After an Ambulatory Reconstruction of the Cruciate Ligament

This study has been withdrawn prior to enrollment.
(Study has never started)
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00285987
First received: February 1, 2006
Last updated: December 19, 2007
Last verified: December 2007
  Purpose

Study to compare the quality of life after reconstruction of the cruciate ligament in hospitalized versus day-clinic patient


Condition Intervention
Rupture of the Cruciate Ligament
Procedure: Reconstruction of the cruciate ligament

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Quality of Life After an Ambulatory Reconstruction of the Cruciate Ligament

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Quality of life

Estimated Enrollment: 500
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • rupture of the cruciate ligament

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00285987

Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00285987     History of Changes
Other Study ID Numbers: 2000/282
Study First Received: February 1, 2006
Last Updated: December 19, 2007
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on October 23, 2014